27th Jul 2020 18:11
Oncimmune Holdings PLC - immunodiagnostics - Roche Holdings AG has exercised option to expand cornerstone contract signed in late May. Oncimmune has profiled patient samples collected by Roche during its cancer immunotherapy trials, and has agreed to increase the number of patient samples to be profiled.
Current stock price: 133.00 pence
Year-to-date change: Increased more than threefold from 38.50 pence.
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Oncimmune